...
首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy.
【24h】

On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy.

机译:关于使用超极化氦气MRI进行保形避免肺部放疗。

获取原文
获取原文并翻译 | 示例
           

摘要

We wanted to illustrate the feasibility of using hyperpolarized helium magnetic resonance imaging (HPH-MRI) to obtain functional information that may assist in improving conformal avoidance of ventilating lung tissue during thoracic radiotherapy. HPH-MRI images were obtained from a volunteer patient and were first fused with a proton density-weighted (PD(w)) MRI to provide corresponding anatomic detail; they were then fused with the treatment planning computed tomography scan of a patient from our treatment planning database who possessed equivalent thoracic dimensions. An optimized treatment plan was then generated using the TomoTherapy treatment planning system, designating the HPH-enhancing regions as ventilation volume (VV). A dose-volume histogram compares the dosimetry of the lungs as a paired organ, the VV, and the lungs minus the VV. The clinical consequences of these changes was estimated using a bio-effect model, the parallel architecture model, or the local damage (f(dam)) model. Model parameters were chosen from published studies linking the incidence of grade 3+ pneumonitis, with the dose and volume irradiated. For two hypothetical treatment plans of 60 Gy in 30 fractions delivered to a right upper-lobe lung mass, one using and one ignoring the VV as an avoidance structure, the mean normalized total dose (NTD(mean)) values for the lung subvolumes were: lungs = 12.5 Gy vs. 13.52 Gy, VV = 9.94 Gy vs. 13.95 Gy, and lungs minus VV = 16.69 Gy vs. 19.16 Gy. Using the f(dam) values generated from these plans, one would predict a reduction of the incidence of grade 3+ radiation pneumonitis from 12%-4% when compared with a conventionally optimized plan. The use of HPH-MRI to identify ventilated lung subvolumes is feasible and has the potential to be incorporated into conformal avoidance treatment planning paradigms. A prospective clinical study evaluating this imaging technique is being developed.
机译:我们想说明使用超极化氦核磁共振成像(HPH-MRI)来获取功能信息的可行性,这些信息可能有助于改善在胸部放疗期间避免对呼吸性肺组织进行保形避免。 HPH-MRI图像是从一名自愿患者那里获得的,首先将其与质子密度加权(PD(w))MRI融合以提供相应的解剖学细节;然后将它们与我们的治疗计划数据库中具有等效胸廓尺寸的患者的治疗计划计算机断层扫描相融合。然后使用TomoTherapy治疗计划系统生成优化的治疗计划,并将HPH增强区域指定为通气量(VV)。剂量-体积直方图比较了作为配对器官的肺的剂量测定,VV和减去VV的肺。这些变化的临床后果是使用生物效应模型,并行架构模型或局部破坏(f(dam))模型估算的。模型参数是从已发表的研究中选择的,这些研究将3级以上的肺炎的发生率与照射的剂量和体积联系起来。对于两种假设的治疗方案,即将30个部分中的60 Gy输送到右上肺部肿块,一种使用而另一种忽略VV作为避免结构,则肺亚体积的平均标准化总剂量(NTD(mean))值为:肺= 12.5 Gy对13.52 Gy,VV = 9.94 Gy对13.95 Gy,而肺减去VV = 16.69 Gy对19.16 Gy。使用这些计划生成的f(dam)值,与传统的优化计划相比,可以预测3级以上放射性肺炎的发生率将从12%-4%降低。使用HPH-MRI来识别通气的肺亚容积是可行的,并且有可能被整合到适形回避治疗计划范式中。正在评估该成像技术的前瞻性临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号